459 related articles for article (PubMed ID: 26139689)
1. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
Leung ST; Sung TH; Wan AY; Leung KW; Kan WK
Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689
[TBL] [Abstract][Full Text] [Related]
2. Endovascular stenting for end-stage lung cancer patients with superior vena cava syndrome post first-line treatments - A single-center experience and literature review.
Kuo TT; Chen PL; Shih CC; Chen IM
J Chin Med Assoc; 2017 Aug; 80(8):482-486. PubMed ID: 28501315
[TBL] [Abstract][Full Text] [Related]
3. Brachiocephalic-superior vena cava metallic stenting in malignant superior vena cava obstruction.
Lau KY; Tan LT; Wong WW; Lee AS
Ann Acad Med Singap; 2003 Jul; 32(4):461-5. PubMed ID: 12968550
[TBL] [Abstract][Full Text] [Related]
4. [Observation of endovascular stent insertion for non-small cell lung cancer patients with superior vena cava syndrome].
Li F; Sun X; Liang S; Jiang S; Mao L
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):47-51. PubMed ID: 25877319
[TBL] [Abstract][Full Text] [Related]
5. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy.
Nicholson AA; Ettles DF; Arnold A; Greenstone M; Dyet JF
J Vasc Interv Radiol; 1997; 8(5):781-8. PubMed ID: 9314368
[TBL] [Abstract][Full Text] [Related]
6. A new nitinol stent for use in superior vena cava syndrome. Initial clinical experience.
Andersen PE; Midtgaard A; Brenøe AS; Elle B; Duvnjak S
J Cardiovasc Surg (Torino); 2015 Dec; 56(6):877-81. PubMed ID: 26212865
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous transluminal stenting for superior vena cava syndrome caused by malignant tumors: a single-center retrospective study.
Liu H; Li Y; Wang Y; Yan L; Zhou P; Han X
J Cardiothorac Surg; 2021 Mar; 16(1):39. PubMed ID: 33743767
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous endovascular Y-stenting of a malignant superior vena cava and innominate vein obstruction.
Cordial R; Moussavian MR; Corvalan J; Görtz H; Teßarek J
Vasc Endovascular Surg; 2014 Jan; 48(1):77-9. PubMed ID: 24122722
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous stenting of superior vena cava syndrome: treatment outcome in patients with benign and malignant etiology.
Barshes NR; Annambhotla S; El Sayed HF; Huynh TT; Kougias P; Dardik A; Lin PH
Vascular; 2007; 15(5):314-21. PubMed ID: 17976332
[TBL] [Abstract][Full Text] [Related]
10. Stent placement for the treatment of malignant superior vena cava syndrome - a single-center series of 56 patients.
Sobrinho G; Aguiar P
Arch Bronconeumol; 2014 Apr; 50(4):135-40. PubMed ID: 24360084
[TBL] [Abstract][Full Text] [Related]
11. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome.
Lanciego C; Pangua C; Chacón JI; Velasco J; Boy RC; Viana A; Cerezo S; García LG
AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456
[TBL] [Abstract][Full Text] [Related]
12. Superior Vena Cava Obstruction Complicated by Upper Extremity Deep Vein Thrombosis: A Novel Endovascular Approach.
Khalifa M; Patel N; Moser S
Vasc Endovascular Surg; 2016 Apr; 50(3):180-2. PubMed ID: 27036674
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of stent placement for vena cava syndrome: phase II trial and phase III randomized controlled trial.
Takeuchi Y; Arai Y; Sone M; Sugawara S; Aramaki T; Sato R; Kichikawa K; Tanaka T; Morishita H; Ito T; Yamakado K; Baba Y; Kobayashi T
Support Care Cancer; 2019 Mar; 27(3):1081-1088. PubMed ID: 30112721
[TBL] [Abstract][Full Text] [Related]
14. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy.
Fagedet D; Thony F; Timsit JF; Rodiere M; Monnin-Bares V; Ferretti GR; Vesin A; Moro-Sibilot D
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):140-9. PubMed ID: 22146975
[TBL] [Abstract][Full Text] [Related]
15. Vascular stenting for palliation of superior vena cava obstruction in non-small-cell lung cancer patients: a future 'standard' procedure?
Greillier L; Barlési F; Doddoli C; Durieux O; Torre JP; Gimenez C; Kleisbauer JP
Respiration; 2004; 71(2):178-83. PubMed ID: 15031575
[TBL] [Abstract][Full Text] [Related]
16. [Stenting for superior vena cava obstruction associated with lung cancer: monocentric study].
Pierre MC; Chabbert V; Lozano S; Bigay-Game L; Lévêque N; Desloques L; Otal P; Rousseau H; Didier A; Mazières J
Rev Mal Respir; 2009 Sep; 26(7):744-50. PubMed ID: 19953016
[TBL] [Abstract][Full Text] [Related]
17. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome.
Lanciego C; Chacón JL; Julián A; Andrade J; López L; Martinez B; Cruz M; García-García L
AJR Am J Roentgenol; 2001 Sep; 177(3):585-93. PubMed ID: 11517051
[TBL] [Abstract][Full Text] [Related]
18. Benign superior vena cava syndrome: stenting is now the first line of treatment.
Rizvi AZ; Kalra M; Bjarnason H; Bower TC; Schleck C; Gloviczki P
J Vasc Surg; 2008 Feb; 47(2):372-80. PubMed ID: 18241760
[TBL] [Abstract][Full Text] [Related]
19. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava.
Nagata T; Makutani S; Uchida H; Kichikawa K; Maeda M; Yoshioka T; Anai H; Sakaguchi H; Yoshimura H
Cardiovasc Intervent Radiol; 2007; 30(5):959-67. PubMed ID: 17546400
[TBL] [Abstract][Full Text] [Related]
20. Endovascular treatment of malignant superior vena cava syndrome: is bilateral wallstent placement superior to unilateral placement?
Dinkel HP; Mettke B; Schmid F; Baumgartner I; Triller J; Do DD
J Endovasc Ther; 2003 Aug; 10(4):788-97. PubMed ID: 14533962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
